Monday, August 13, 2012

Sanofi receives USFDA approval for Auvi- Q ( epinephrine injection)

Auvi-Q is the first-and-only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process. Auvi-Q  is the only epinephrine auto-injector that talks users through each step of the injection process Sanofi US licensed the North American commercialization rights to Auvi-Q from Intelliject, Inc., which has retained commercialization rights for the rest of the world.

Auvi-Q contains epinephrine,a well-established, first-line treatment for severe, life-threatening allergic reactionsthat may occur as a result of exposure to allergens including nuts, shellfish, dairy, eggs, insect bites, latex and medication, among other allergens.